SAN FRANCISCO (CBS.MW) -- Dade Behring Holdings Inc. said after the bell Thursday that its NT-proBNP test has received clearance for expanded use from the U.S. Food and Drug Administration. The test ...

Congestive heart failure (CHF) is the term used to describe what happens when the heart is unable to pump enough blood to meet the body’s needs. (It should not be confused with cardiac arrest in which ...

Diastolic heart failure means there’s a problem with your heart’s ability to fill with blood. It’s a type of congestive heart failure where your heart cannot work efficiently, leading to fluid ...

Imbria Pharmaceuticals’ heart failure medicine met the safety and tolerability goals in a phase 2 trial while also improving results on a cardiopulmonary exercise test, with patients reporting other ...

(WISH) — The use of smartwatches in detecting congestive heart failure could revolutionize early diagnosis and treatment, offering a promising tool for patients and health care providers alike.

Managing heart failure can be challenging as patients typically need to wait for blood tests to be performed and processed by a skilled technician. This creates a noticeable lag between the ...

Systolic congestive heart failure involves the left side of your heart losing its ability to pump effectively. Common symptoms include shortness of breath, weight gain, and swelling in your legs or ...

You can follow a treatment plan and take medications as a doctor prescribes to manage congestive heart failure. Eat a heart-healthy diet and stay physically active to slow heart failure progression.

A new AI blood test may forecast major cardiovascular disease risks years before clinical onset by reading real-time ...

Excessive fatigue is a common symptom of congestive heart failure, but there are steps you can take to relieve it. Congestive heart failure (CHF) is a type of heart failure that causes congestion in ...

TULSA, Okla. — Some people with congestive heart failure are getting the chance to try a new treatment. Saint Francis is in the middle of a two-year double-blind clinical trial for a device that could ...